Why Fletcher Building, Magellan, Sezzle, & Starpharma are racing higher

These ASX shares are ending the week strongly…
The post Why Fletcher Building, Magellan, Sezzle, & Starpharma are racing higher appeared first on The Motley Fool Australia. –

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to finish the week on a strong note. At the time of writing, the benchmark index is up 0.8% to 7,314.1 points.

Four ASX shares that are climbing more than most today are listed below. Here’s why they are racing higher:

Fletcher Building Limited (ASX: FBU)

The Fletcher Building share price is up over 2% to $6.90. Investors have been buying the building products company’s shares following the release of a bullish broker note out of UBS. According to the note, the broker has upgraded the company’s shares to a buy rating with an NZ$8.00 (A$7.59) price target. UBS expects Fletcher Building to benefit from the reopening of the ANZ economy.

Magellan Financial Group Ltd (ASX: MFG)

The Magellan share price is up 5% to $33.78. On Thursday, analysts at Macquarie upgraded this fund manager’s shares to an outperform rating with a $38.00 price target. Macquarie made the move on valuation grounds following a significant de-rating. It feels Magellan’s shares are too cheap to ignore, especially given the potential for a dividend yield of ~7% in FY 2022.

Sezzle Inc (ASX: SZL)

The Sezzle share price is up a further 5% to $5.92. Investors have been buying the buy now, pay later (BNPL) provider’s shares this week after US retailer Target launched Sezzle’s BNPL service across its network. Consumers shopping with the retail giant ahead of the holiday season will now be able to pay for their purchases in instalments through Sezzle or rival Affirm.

Starpharma Holdings Limited (ASX: SPL)

The Starpharma share price is up 2% to $1.22. This morning the dendrimer products developer announced a sales and distribution agreement for Viraleze with Admenta Italia Group. It is a leading pharmaceutical retail and wholesale distribution company in Italy. Viraleze is a broad-spectrum antiviral nasal spray which is applied in the nose to provide a physical barrier between viruses and the nasal mucous membrane. The product traps and irreversibly inactivates virus, including SARS-CoV-2.

The post Why Fletcher Building, Magellan, Sezzle, & Starpharma are racing higher appeared first on The Motley Fool Australia.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of August 16th 2021

More reading

Here’s why these top brokers reckon the Magellan (ASX:MFG) share price is cheap
The Sezzle (ASX:SZL) share price has leapt 19% in 2 days. Here’s why
How did ASX fintech shares perform in the FY22 first quarter?

Here’s why the Starpharma (ASX:SPL) share price is charging 4% higher today
Why A2 Milk, Magellan, Santos, & Whitehaven Coal shares are falling

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended Starpharma Holdings Limited. The Motley Fool Australia has recommended Starpharma Holdings Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!